Kyung Hyun Lee

Title: The Innovative Contributions of Kyung Hyun Lee

Introduction

Kyung Hyun Lee is a prominent inventor based in Seongnam-si, South Korea. He has made significant strides in the field of RNA technology, particularly with his innovative work on self-circularization RNA constructs. His contributions have the potential to advance various applications in biotechnology and medicine.

Latest Patents

Kyung Hyun Lee holds a patent for a self-circularization RNA construct. This construct can be expressed in a DNA vector and simultaneously circularized through a self-targeting and splicing reaction to form a circRNA. The circRNA can consist solely of a gene of interest, which may be coding, non-coding, or a combination of both. This gene of interest allows for the rapid expression of peptides or proteins. The formed circRNA possesses a circular structure, providing stability and a high half-life due to the protection of its 5′ and 3′ ends. Consequently, functional RNA such as miRNA, anti-miRNA, siRNA, shRNA, aptamer, and mRNA vaccines can be produced as stable circRNA within cells.

Career Highlights

Kyung Hyun Lee is associated with Rznomics Inc., where he continues to push the boundaries of RNA research. His work has garnered attention for its innovative approach to RNA constructs, which could lead to breakthroughs in therapeutic applications.

Collaborations

He collaborates with notable colleagues, including Seong-Wook Lee and Seung Ryul Han, who contribute to the advancement of their shared research goals.

Conclusion

Kyung Hyun Lee's innovative work in RNA technology exemplifies the potential of self-circularization constructs in biotechnology. His contributions are paving the way for future advancements in medical applications and therapeutic solutions.